about
Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.Novel thrombin and factor Xa inhibitors: challenges to reversal of their anticoagulation effects.Reversal of anticoagulant effects in patients with intracerebral hemorrhage.New strategies for effective treatment of vitamin K antagonist-associated bleeding.How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?Transfusion management of factor V deficiency: three case reports and review of the literature.Weathering the storm: A case of thyroid storm refractory to conventional treatment benefiting from therapeutic plasma exchangeIs platelet transfusion necessary in cirrhotic patients with splenomegaly?Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemiaEvaluating the effects of oseltamivir phosphate on platelet counts: a retrospective reviewRole of plasma exchange in stiff person syndromeHypercalcemia and Altered Mental StatusProlonged partial thromboplastin time: To mix or not to mix - is that the question?
P50
Q33414120-E5CE8944-0902-4C68-B8E8-14FA16C70133Q38150635-77F65F8A-5EA5-440E-9DD5-6A739964B1FEQ38269290-00D3CE5E-D3FB-4E70-B14B-9D9C0BE5261EQ38543287-D365E76A-F048-4689-A225-1FF1A14E8E11Q39997164-44811D78-9159-4327-8629-713B654B9C46Q40295049-70DBE7F1-3A22-42E7-8F39-71C886D85AF8Q46259252-4CF9968E-91B5-4F0D-BDD5-DA9520ED1E1AQ47267034-693D5EB7-E221-459F-B45E-051CD56A7D1CQ50865356-589DE634-8C9B-40DF-A27C-8C54641EBC13Q57463582-F1C36F39-44A8-465A-BDA6-6CCA796A3B11Q86489618-C37F886C-FAE5-4366-A1BC-01F924CFD23CQ90375609-2AFD5B02-E63D-44E8-BD5C-7F4AE281AA6BQ92604213-40581346-07AA-4A35-9493-98374FD4C895Q92883987-AFE608BB-E506-4322-A5D9-FCD49B7A1A16Q93114857-9EBB2A73-4BA5-476E-BB30-EB12F4BA7B1BQ93375419-5B10762F-AC34-417F-A7FF-45F3BC12CF81
P50
description
researcher ORCID ID = 0000-0001-9703-5047
@en
name
Sean Yates
@ast
Sean Yates
@en
Sean Yates
@es
Sean Yates
@nl
type
label
Sean Yates
@ast
Sean Yates
@en
Sean Yates
@es
Sean Yates
@nl
prefLabel
Sean Yates
@ast
Sean Yates
@en
Sean Yates
@es
Sean Yates
@nl
P1153
55879930600
P31
P496
0000-0001-9703-5047